Evolus (EOLS) reported a third-quarter loss of $0.09 per share, wider than the Zacks consensus estimate of a $0.05 loss. The loss improved from $0.14 per share a year earlier, while revenue beat estimates and grew 13%. The company recorded its fourth consecutive quarter of positive adjusted EBITDA. It reaffirmed 2026 revenue guidance of $330 million to $337 million and set a 2028 revenue target of $450 million to $500 million.
Evolus posted a quarterly loss of $0.09 per share, wider than the $0.05 loss expected by analysts despite year-over-year improvement.
Read the full story